Literature DB >> 25296645

Cytotoxic effects of ropivacaine, bupivacaine, and lidocaine on rotator cuff tenofibroblasts.

Chang-Meen Sung1, Young-Sool Hah2, Jin-Su Kim3, Jeoung-Bin Nam4, Ra Jeong Kim5, Sang-Jin Lee6, Hyung Bin Park7.   

Abstract

BACKGROUND: Concern has recently arisen over the safety of local anesthetics used on human tissues. HYPOTHESIS: Aminoamide local anesthetics have cytotoxic effects on human rotator cuff tenofibroblasts. STUDY
DESIGN: Controlled laboratory study.
METHODS: Cultured human rotator cuff tenofibroblasts were divided into control, phosphate buffered saline (PBS), and local anesthetic study groups; the PBS study group was further subdivided by pH level (pH 7.4, 6.0, and 4.4). The 6 local anesthetic subgroups (0.2% and 0.75% ropivacaine, 0.25% and 0.5% bupivacaine, and 1% and 2% lidocaine) were also studied at 10% dilutions of their original concentrations. Exposure times were 5, 10, 20, 40, or 60 minutes for the higher concentrations and 2, 6, 12, 24, 48, or 72 hours for the lower concentrations. Cell viability was evaluated through live, apoptotic, and necrotic cell rates using the annexin V-propidium iodide double-staining method. Intracellular reactive oxygen species (ROS) and the activity of mitogen-activated protein kinases (MAPKs) and caspase-3/7 were investigated.
RESULTS: The control and PBS groups showed no significant differences in cell viability (P > .999). In the local anesthetic study groups, cell viability decreased significantly with increases in anesthetic concentrations (P < .001) and exposure times (P < .001), with the exception of the lidocaine subgroups, where this effect was masked by the very high cytotoxicity of even low concentrations. Among the studied local anesthetic subgroups, 0.2% ropivacaine was the least toxic. The levels of intracellular ROS of each local anesthetic subgroup also increased significantly (P < .05). The studied local anesthetics showed increases in the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK), and p38 as well as in levels of caspase-3/7 activity (P < .001).
CONCLUSION: The cytotoxicity of the anesthetics studied to tenofibroblasts is dependent on exposure time and concentration. Of the evaluated anesthetics, ropivacaine is the least toxic in the clinically used concentration. The studied anesthetics induce tenofibroblast cell death, mediated by the increased production of ROS, by the increased activation of ERK1/2, JNK, and p38 and by the activation of caspase-3/7. CLINICAL RELEVANCE: This study identified the cytotoxic mechanisms of aminoamide local anesthetics acting on rotator cuff tenofibroblasts. The greatest margin of safety was found in lower anesthetic concentrations in general and more specifically in the use of ropivacaine.
© 2014 The Author(s).

Entities:  

Keywords:  aminoamide local anesthetics; cytotoxicity; rotator cuff; tenofibroblast

Mesh:

Substances:

Year:  2014        PMID: 25296645     DOI: 10.1177/0363546514550991

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  13 in total

1.  Local infiltration analgesia versus continuous interscalene brachial plexus block for shoulder replacement pain: a randomized clinical trial.

Authors:  Karen T Bjørnholdt; Jan M Jensen; Thomas F Bendtsen; Kjeld Søballe; Lone Nikolajsen
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-08-15

Review 2.  Platelet-rich plasma: combinational treatment modalities for musculoskeletal conditions.

Authors:  Isabel Andia; Michele Abate
Journal:  Front Med       Date:  2017-10-18       Impact factor: 4.592

3.  Corticosteroid and Local Anesthetic Use Trends for Large Joint and Bursa Injections: Results of a Survey of Sports Medicine Physicians.

Authors:  Daniel M Cushman; Masaru Teramoto; Alexandra Asay; Nathan D Clements; Zachary L McCormick
Journal:  PM R       Date:  2020-11-23       Impact factor: 2.218

4.  Comparison between Collagen and Lidocaine Intramuscular Injections in Terms of Their Efficiency in Decreasing Myofascial Pain within Masseter Muscles: A Randomized, Single-Blind Controlled Trial.

Authors:  Aleksandra Nitecka-Buchta; Karolina Walczynska-Dragon; Jolanta Batko-Kapustecka; Mieszko Wieckiewicz
Journal:  Pain Res Manag       Date:  2018-06-03       Impact factor: 3.037

5.  Comparison between xCELLigence biosensor technology and conventional cell culture system for real-time monitoring human tenocytes proliferation and drugs cytotoxicity screening.

Authors:  Chih-Hao Chiu; Kin Fong Lei; Wen-Ling Yeh; Poyu Chen; Yi-Sheng Chan; Kuo-Yao Hsu; Alvin Chao-Yu Chen
Journal:  J Orthop Surg Res       Date:  2017-10-16       Impact factor: 2.359

6.  ROS-mediated lysosomal membrane permeabilization is involved in bupivacaine-induced death of rabbit intervertebral disc cells.

Authors:  Xianyi Cai; Yunlu Liu; Yiqiang Hu; Xianzhe Liu; Hongyan Jiang; Shuhua Yang; Zengwu Shao; Yun Xia; Liming Xiong
Journal:  Redox Biol       Date:  2018-06-27       Impact factor: 11.799

7.  The proper concentrations of dextrose and lidocaine in regenerative injection therapy: in vitro study.

Authors:  Min Seok Woo; Jiyoung Park; Seong-Ho Ok; Miyeong Park; Ju-Tae Sohn; Man Seok Cho; Il-Woo Shin; Yeon A Kim
Journal:  Korean J Pain       Date:  2021-01-01

8.  Neurotropin protects rotator cuff tendon cells from lidocaine-induced cell death.

Authors:  Ryunosuke Abe; Hiroki Ohzono; Masafumi Gotoh; Yosuke Nakamura; Hirokazu Honda; Hidehiro Nakamura; Shinichiro Kume; Takahiro Okawa; Naoto Shiba
Journal:  Clin Shoulder Elb       Date:  2021-12-01

9.  In vitro toxicity of local anaesthetics and corticosteroids on supraspinatus tenocyte viability and metabolism.

Authors:  Clayton W Nuelle; Cristi R Cook; Aaron M Stoker; James L Cook; Seth L Sherman
Journal:  J Orthop Translat       Date:  2016-09-28       Impact factor: 5.191

10.  Dual Action of Mexiletine and Its Pyrroline Derivatives as Skeletal Muscle Sodium Channel Blockers and Anti-oxidant Compounds: Toward Novel Therapeutic Potential.

Authors:  Michela De Bellis; Francesca Sanarica; Alessia Carocci; Giovanni Lentini; Sabata Pierno; Jean-François Rolland; Diana Conte Camerino; Annamaria De Luca
Journal:  Front Pharmacol       Date:  2018-01-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.